A detailed history of Sonen Capital LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Sonen Capital LLC holds 3,417 shares of EW stock, worth $259,418. This represents 0.5% of its overall portfolio holdings.

Number of Shares
3,417
Previous 8,282 58.74%
Holding current value
$259,418
Previous $573,000 54.62%
% of portfolio
0.5%
Previous 1.14%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024

SELL
$61.71 - $77.76 $300,219 - $378,302
-4,865 Reduced 58.74%
3,417 $260,000
Q3 2023

Nov 09, 2023

BUY
$69.28 - $93.38 $350,071 - $471,849
5,053 Added 156.49%
8,282 $573,000
Q2 2023

Aug 07, 2023

BUY
$81.41 - $94.33 $262,872 - $304,591
3,229 New
3,229 $304,000
Q1 2022

May 09, 2022

SELL
$101.96 - $128.34 $225,841 - $284,273
-2,215 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$106.37 - $130.68 $235,609 - $289,456
2,215 New
2,215 $287,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Sonen Capital LLC Portfolio

Follow Sonen Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sonen Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sonen Capital LLC with notifications on news.